Aura Biosciences Inc Earnings

The next earnings date for Aura Biosciences Inc is May 7, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Aura Biosciences Inc Earnings

Report DateEstimated Earnings Per Share
05/07/2026$-0.52

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Aura Biosciences Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
03/31/2026---$-0.3714.84%
11/06/2025---$0100.00%
08/08/2025---$0100.00%
11/13/2024---$-0.424.55%
08/07/2024Before Market$-0.418.89%
05/09/2024Before Market$-0.4018.37%
03/12/2024After Market$-0.56-36.59%
11/09/2023After Market$-0.487.69%
08/09/2023Before Market$-0.482.04%
05/11/2023After Market$-0.4614.81%
03/15/2023After Market$-0.55-5.77%
11/10/2022Before Market$-0.54-5.88%
08/11/2022After Market$-0.460.00%
05/12/2022After Market$-0.440.00%
03/23/2022After Market$-2.51-543.59%
11/24/2021After Market$-0.2544.44%
06/30/2021---$-28.52---
03/31/2021---$-20.62---
12/31/2020---$-16.65---
09/30/2020---$-16.65---
06/30/2020---$-22.13---
03/31/2020---$-27.27---

More About Aura Biosciences Inc

Country
USA
Full Time Employees
113

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Aura Biosciences Inc Earnings” Can Refer to the Aura Biosciences Inc Earnings Date

Some people say “Aura Biosciences Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Aura Biosciences Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Aura Biosciences Inc Stock on the Earnings Date

If you own Aura Biosciences Inc stock (AURA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Aura Biosciences Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Aura Biosciences Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Aura Biosciences Inc Earnings

You can contact us any time if you would like to ask questions about Aura Biosciences Inc earnings or anything else related to the stock market.